Getinge’s disappointing run continued in Q4, with both the top- and bottom-line coming below consensus expectations. Both sales (SEK9.5bn) and order intake (organic basis) contracted 2.3% and 1.1%, respectively, primarily due to weak Surgical Workflows following the subdued infection control and integrated workflow businesses. Organic sales declined by 0.9% at the Patient & Post-Acute Care (P&PAC) segment on account of the dip in hygiene-related products; sales of medical beds a
10 Feb 2017
Uncertainties abound
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Uncertainties abound
Getinge AB Class B (GTN:FRA) | 0 0 0.9% | Mkt Cap: 25,911m
- Published:
10 Feb 2017 -
Author:
Jyoti Prakash -
Pages:
4
Getinge’s disappointing run continued in Q4, with both the top- and bottom-line coming below consensus expectations. Both sales (SEK9.5bn) and order intake (organic basis) contracted 2.3% and 1.1%, respectively, primarily due to weak Surgical Workflows following the subdued infection control and integrated workflow businesses. Organic sales declined by 0.9% at the Patient & Post-Acute Care (P&PAC) segment on account of the dip in hygiene-related products; sales of medical beds a